CLICK HERE to watch Dr James Del Rosso provide an in-depth overview of Nemluvio (nemolizumab) for atopic dermatitis

Self-guided cognitive behavioral therapy intervention noninferior to clinician-guided therapy

Risk factors for subsequent neoplasm risk include age 50 years and older at BMT, male sex, post-BMT immunosuppression

FDA Approves VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

• EFFICACY: In...

Findings for primary tumors of 0.8 to 1.0 mm versus those <0.8 mm

All patients receiving surgery/radiotherapy alone or with chemotherapy had improvement or stability of alopecia with LDOM

Findings seen for children with and without comorbidities, such as asthma, allergic rhinitis, food allergies

Significantly lower risks for melanoma, lung cancer, bladder cancer seen for patients with vitiligo

TMB significantly associated with older age at diagnosis, history of nonmelanoma skin cancer, head and neck tumors

Risk 25 percent higher when comparing matched individuals with and without celiac disease

Older age, female sex, and allergic comorbidities increase risk for developing Meniere disease

Safety profile consistent, clinical response durable among patients with moderate-to-severe plaque psoriasis

Patients with upstaged tumors experience higher overall and melanoma-specific mortality than those with nonupstaged tumors

Association persists after adjustment for age, BMI, alcohol intake, and comorbidities

Greater proportion of those receiving nemolizumab monotherapy versus placebo achieved itch response, IGA success

Significant differences seen in distributions of primary tumor location by sex, race/ethnicity for pediatric, AYA groups

Most Merkel cell carcinoma cases are due to ambient ultraviolet radiation, Merkel cell polyomavirus

Approval based on phase 3 trials showing clinical response at 16 weeks, with sustained benefit at 48 weeks

Seventy-six items achieved consensus, including indications for LDOM versus topical minoxidil, dosing for adults and teens, contraindications

The dual IL-17A and IL-17F inhibitor demonstrated significant symptom reduction and sustained efficacy through 48 weeks

TeleTeam detected 11 of 13 skin cancers with clinical photos, dermoscopy alone, with accuracy of 91 percent

Predominant allergens identified in cosmetics include nickel sulfate, fragrance mix I, cobalt chloride, para-phenylenediamine base

Authors suggest reduced dermatology access led to a 'downstream increase of thicker melanoma'